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T cells recognize proteolytic fragments of antigens that are presented to them on major
histocompatibility complex (MHC) molecules. MHC class I molecules present primarily
products of proteasomal proteolysis to CD8+ T cells, while MHC class II molecules display
mainly degradation products of lysosomes for stimulation of CD4+T cells. Macroautophagy
delivers intracellular proteins to lysosomal degradation, and contributes in this fashion to
the pool of MHC class II displayed peptides. Both self- and pathogen-derived MHC class
II ligands are generated by this pathway. In addition, however, recent evidence points
also to regulation of extracellular antigen processing by macroautophagy. In this review,
I will discuss these two aspects of antigen processing for MHC class II presentation via
macroautophagy, namely its inﬂuence on intracellular and extracellular antigen presentation
to CD4+ T cells.
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INTRODUCTION
T cells recognize antigenic fragments presented to them by
major histocompatibility complex (MHC) molecules. CD4+ T
helper cells,whichorchestrate adaptive humoral and cell-mediated
immune responses, are stimulated by MHC class II molecules.
These are present in the steady-state on antigen presenting cells
(APCs), like B cells, macrophages and dendritic cells, leukocytes
that are thought to initiate immune responses, but they can be
up-regulated on most human cells upon inﬂammation or activa-
tion (Neefjes et al., 2011). Antigenic fragments and self-peptides
are loaded onto MHC class II molecules in late endosomes or
MHC class II containing compartments (MIICs). Most likely
proteins that are transported to MIICs bind to MHC class II
and are then trimmed by lysosomal proteolysis to yield pep-
tides of at least nine amino acids length, but often 15-mers or
longer, which then stabilize MHC class II for export from MIICs
to the cell surface for T cell stimulation (Trombetta and Mell-
man, 2005). In addition to proteases, the oxidoreductase GILT
(gamma-IFN-inducible lysosomal thiol reductase) participates in
the unfolding of antigens by reducing disulﬁde bonds (Maric et al.,
2001). MHC class II molecules reach MIICs with the help of the
invariant chain (Ii), which associates with them in the endoplas-
mic reticulum, where it prevents premature peptide loading onto
MHC class II and guides MHC class II transport to MIICs via
its cytoplasmic tail. Ii is degraded in MIIC by lysosomal hydrol-
ysis, and its last remnant the CLIP peptide (class II associated
invariant chain peptide) is then released from the MHC class
II peptide binding groove under the inﬂuence of the HLA-DM
chaperone, which is negatively regulated by HLA-DO in some
cell types. Some self-protein ligands of MHC class II might reach
the MIICs via a similar route as MHC class II molecules them-
selves. Indeed, membrane proteins including MHC class I and II
constitute around 40% of natural MHC class II ligands (Dengjel
et al., 2005). Classically, endocytosis delivers non-self antigens to
MIICs, but might also account for some surface receptor delivery
for MHC class II loading. However, in B cell lines only around
10% of natural MHC class II ligands are derived from bona ﬁde
extracellular proteins. In addition, a substantial amount of MHC
class II ligands originates from cytosolic and nuclear antigens
(Dengjel et al., 2005). This fraction makes up 20–30% of natural
MHC class II ligands. In this review I will discuss how macroau-
tophagy, a pathway that engulfs cytoplasmic constituents with a
double-membrane surrounded autophagosome and delivers them
to lysosomes for degradation (Figure 1),might contribute not only
to the transport of cytosolic and nuclear antigens to MIICs, but
also how it might facilitate the delivery of endocytosed cargo to
this compartment.
ENDOGENOUS PROCESSING FOR MHC CLASS II
PRESENTATION OF SELF- AND FOREIGN ANTIGENS VIA
AUTOPHAGY
SELF-ANTIGEN PROCESSING BY AUTOPHAGY FOR MHC CLASS II
PRESENTATION ON LEUKOCYTES AND IN THE THYMUS
Indeed, when macroautophagy was induced in B cell lines by star-
vation, cytosolic, and nuclear antigen presentation was increased
by 50%, while membrane bound antigen presentation remained
largely unaffected (Dengjel et al., 2005). For individual ligands the
increase even exceeded 130%. This increase in intracellular anti-
gen presentation correlated with macroautophagy induction as
determined by autophagic vacuole content. Among the cytosolic
MHCclass II ligands also two components of themacroautophagic
machinery could be found, namely LC3 and GABARAP (Deng-
jel et al., 2005; Suri et al., 2008). Both of them are mammalian
homologs of the autophagy related gene (atg) product Atg8,which
are coupled to the autophagosome membrane and involved in
the extension of the double-membrane around the cargo and
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FIGURE 1 | Regulation of intra- and extracellular antigen processing for
MHC class II presentation by macroautophagy. Left side:
Autophagosomes, which recruit their cargo through binding to Atg8/LC3, fuse
with MHC class II containing compartments (MIICs), in which limited
lysosomal hydrolysis breaks down these antigens for MHC class II loading
with the assistance of HLA-DM (H2-M in mice). Right side: phagosomes,
especially those carryingToll-like receptor (TLR) ligands or apoptotic cells, get
decorated with Atg8/LC3, which enhances fusion with lysosomes, and might
also increase fusion with MIICs for antigen loading onto MHC class II
molecules.
closure of the ﬁnal autophagosomes, as well as substrate recruit-
ment into the autophagosome (Weidberg et al., 2010, 2011a,b).
Interestingly, Atg8 homologs are also the only essential macroau-
tophagy proteins that remain with the completed autophagosome
on its inner membrane and get degraded with the autophago-
some cargo by lysosomal proteolysis. Therefore, their turn-over
can be monitored to analyze macroautophagy. These ﬁndings sug-
gest that autophagosome cargo, including LC3 and GABARAP
proteins gain access to MHC class II presentation and, therefore,
autophagosomes might frequently fuse with MIICs. Indeed, such
fusion events were observed in epithelial cells that expressed MHC
class II upon IFN-γ treatment and also B cell lines and dendritic
cells, as classical APCs (Schmid et al., 2007). The fusion vesicles
contained hallmarks of MIICs with expression of HLA-DM and
the lysosome associated membrane protein (LAMP) 2. Further-
more they resemblemultivesicular bodies (MVBs)withbothMHC
class II and LC3 molecules primarily on the intravesicular mem-
branes. Such autophagosome fusion delivers also melanosomes
and tumor differentiation antigens to MIICs in melanoma cells
(van den Boorn et al., 2011). Thus, autophagosomes fuse quite
frequently with MIICs in APCs and some of their cargo is loaded
onto MHC class II. This self-protein presentation on MHC class
II molecules after macroautophagy seems to be especially impor-
tant during thymic CD4+ T cell education. Indeed, also in thymic
epithelial cells (TECs), which constitutively express MHC class II
molecules, autophagosomes fuse with MIICs (Kasai et al., 2009).
This fusion seems to deliver self-proteins for both positive CD4+ T
cell selection in cortical TECs and negative selection in medullary
TECs (Nedjic et al., 2008). Only some, but not other CD4+ T cell
speciﬁcities were selected by cortical TECs deﬁcient in the essential
autophagy protein Atg5, which is involved in Atg8/LC3 coupling
to the autophagosome membrane. In contrast, CD8+ T cells were
correctly educated through Atg5 deﬁcient thymic cortex. In addi-
tion, defective negative selection through Atg5 deﬁcient thymii
has been suggested to cause autoimmune inﬂammation in the
intestines andother organs. This suggests that a substantial portion
of self-protein derived ligands originates from macroautophagy
cargo and that these are required to positively select some T cell
speciﬁcities through the thymus and to induce central tolerance in
this organ.
ENDOGENOUS ANTIGEN PROCESSING OF VIRAL AND BACTERIAL
ANTIGENS VIA MACROAUTOPHAGY
In addition to self-proteins, some viral and bacterial antigens are
presented on MHC class II molecules after macroautophagy. The
ﬁrst viral example for this pathway was the nuclear antigen 1
(EBNA1) of the human tumor virus Epstein Barr virus (EBV; Palu-
dan et al., 2005). This viral protein,which limits both its translation
and its proteasomal degradation via a glycine–alanine (GA) repeat
domain, is turned over by lysosomal degradation after macroau-
tophagy. The engulfment by autophagosomes leads to MHC class
II presentation on EBV transformed B cells to EBNA1 speciﬁc
CD4+ T cell clones, a T cell speciﬁcity that is consistently found
in healthy EBV carriers (Münz et al., 2000). Its nuclear local-
ization, however, limits antigen processing via macroautophagy,
and EBNA1 that lacks its nuclear localization domain is more
efﬁciently presented to CD4+ T cells (Leung et al., 2010). More
efﬁcient processing of cytosolic EBNA1 via macroautophagy leads
to CD4+ T cell recognition of more EBNA1 derived epitopes on
EBV transformed B cells.
Frontiers in Immunology | Antigen Presenting Cell Biology February 2012 | Volume 3 | Article 9 | 2
Münz MHC class II antigen processing by autophagy
In addition to EBNA1, processing of bacterial antigens has been
reported to require macroautophagy. The bacterial transposon-
derived neomycin phosphotransferase II (NeoR) is presented to
CD4+ T cells after macroautophagic processing for MHC class
II presentation (Nimmerjahn et al., 2003; Comber et al., 2011).
Interestingly and in contrast to EBNA1, forced nuclear local-
ization of this after transfection cytosolic protein resulted in
similar or even slightly enhanced presentation on MHC class
II molecules (Riedel et al., 2008). This presentation was still
dependent on macroautophagy and lysosomal degradation.While
NeoR was in these studies introduced into the cytosol by trans-
fection, some bacteria inject antigens via secretion systems into
the same cellular compartment. Among these is the mycobacte-
rial Ag85B antigen, whose MHC class II presentation by DCs is
enhanced upon macroautophagy stimulation (Jagannath et al.,
2009). DCs with macroautophagically increased Ag85B presen-
tation elicit then more efﬁciently protective immune responses
after vaccination by adoptive transfer. Thus, macroautophagy
might enhance antigen presentation during mycobacterial infec-
tion. Furthermore, Yersinia outer proteins YopE and H block
MHC class II loading via endocytosis. In the absence of this
extracellular antigen processing, YopE fusion proteins get endoge-
nously processed for MHC class II presentation (Russmann
et al., 2010). This antigen processing is sensitive to lysoso-
mal and macroautophagy inhibition. Thus bacterial cytosolic,
and maybe even nuclear antigens are degraded via macroau-
tophagy and this leads to MHC class II presentation to CD4+
T cells.
SUBSTRATE RECRUITMENT FOR ENDOGENOUS MHC CLASS II
ANTIGEN PROCESSING VIA AUTOPHAGY
The above discussed evidence suggests that cytosolic and nuclear
antigens get processed for MHC class II processing via macroau-
tophagy. But how are these substrates recruited to autophago-
somes? In higher eukaryotes two pathways of substrate recruit-
ment to macroautophagy have been described. Both rely on
anchoring of cytoplasmic constituents to Atg8/LC3, presum-
ably on the inner autophagosomal membrane and deliver cell
organelles like mitochondria as well as protein aggregates to
autophagosomes. One pathway uses integral organelle proteins,
like NIX for mitochondria (Schweers et al., 2007; Sandoval
et al., 2008), to recruit them to forming autophagosomes or
autophagosomal membranes to their cargo. The second mech-
anism relies on protein adaptors that link polyubiquitinylated
substrates to Atg8/LC3 via ubiquitin-binding domains (UBA or
UBZ) and LC3 interacting domains (LIRs). The four identi-
ﬁed members of this class of proteins are p62/sequestosome
1, NBR1, NDP52, and optineurin (Bjorkoy et al., 2005; Pankiv
et al., 2007; Kirkin et al., 2009; Thurston et al., 2009; Wild
et al., 2011). They recruit protein aggregates, mitochondria,
and bacterial pathogens, like Salmonella, to autophagosomes.
Because they anchor these substrates to the inner autophagoso-
mal membrane, they end up in the completed autophagosomes
and are degraded with their content. Thus, they can be used
to monitor autophagosome turn-over or macroautophagic ﬂux.
While none of these adaptor proteins has so far been directly
linked to antigen processing for MHC class II presentation,
covalent coupling of antigens to the N-terminus of Atg8/LC3
enhances their presentation on MHC class II molecules to CD4+
T cells by epithelial cells, B cells, and dendritic cells up to
20-fold. Such increase has been observed for the inﬂuenza A
virus antigens matrix protein 1 (MP1; Schmid et al., 2007)
and hemagglutinin (HA; Comber et al., 2011), as well as the
tumor antigen NY-ESO-1 (unpublished data). Delivery of these
fusion constructs to MIICs was dependent on the macroau-
tophagy machinery, namely Atg7 and 12, and mutating the C-
terminal glycine residue of Atg8/LC3, which is used to couple this
protein to the autophagosomal membrane, abolishes enhanced
MHC class II presentation of these fusion constructs (Schmid
and Münz, 2007; Comber et al., 2011). These data argue that
Atg8/LC3 can recruit antigens for MHC class II presentation
to autophagosomes, which then frequently fuse with MIICs. To
which extent the UBA/LIR anchor proteins and organelle spe-
ciﬁc LIR containing proteins contribute to self- and foreign-
protein recruitment for MHC class II presentation remains to be
determined.
EXTRACELLULAR ANTIGEN PROCESSING FOR MHC CLASS II
PRESENTATION WITH THE HELP OF AUTOPHAGY
CHARACTERISTICS OF PROCESSING VESICLES FOR MHC CLASS II
LOADING
Major histocompatibility complex class II containing compart-
ments are usually characterized as late endosomal compartments
with intravesicularmembranes thatmorphologically appear either
as MVBs, multilamellar (MLBs), or electron dense bodies (EDBs;
Stern et al., 2006; Neefjes et al., 2011). Rarely, they have a clear
lysosomal appearance, which suggests that their hydrolytic poten-
tial is controlled, and does not readily degrade antigens and MHC
class II molecules all the way to amino acids. This notion is also
supported by recent studies on limited acidiﬁcation of endo-
somes in dendritic cells by alkalinization via for example reac-
tive oxygen species (ROS) production by phagosomal NADPH
oxidase 2 (NOX2; Savina et al., 2006). Elevated pH causes less
efﬁcient hydrolysis by for example lysosomal cathepsins. Along
these lines MHC class II antigen presentation of macroautophagy
substrates can be enhancedby slightly neutralizing the endolysoso-
mal compartment with pharmacological reagents in macrophages
(Brazil et al., 1997). In support of these cell biological stud-
ies, dendritic cells, and macrophages handle antigen also differ-
ently in vivo. While macrophages, which have a decreased ability
to initiate immune responses, degrade injected antigen rapidly
within 1 day, dendritic cells, superior in activation of adaptive
immune compartments, retain injected antigens even 2 days after
injection (Delamarre et al., 2005). Accordingly, antigen formu-
lations, which are highly sensitive to lysosomal degradation are
less well presented to CD4+ T cells and induce weaker immune
responses than antigens with some resistance to hydrolysis (Dela-
marre et al., 2006). These data suggest that extracellular antigen
is more efﬁciently presented on MHC class II molecules, when it
is degraded less efﬁciently, and that rapid fusion with lysosomes
would rather be detrimental for CD4+ T cell stimulation. This
has to be kept in mind when we now discuss what the macroau-
tophagic machinery contributes to phagocytosis and phagosome
maturation.
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ALTERATIONS OF PHAGOSOMES THROUGH THE MACROAUTOPHAGY
MACHINERY
Fusion of autophagosomes and endosomes is a frequent process
in higher eukaryotic cells and the resulting vesicles were termed
amphisomes (Berg et al., 1998). While Rab7 seems to be involved
in direct fusion of autophagosomes with lysosomes, endosome,
and MVB fusion is mediated by Rab11 (Gutierrez et al., 2004b;
Fader et al., 2008). Amphisomes are then also delivered to lyso-
somes. Thus, autophagosomes might modify phagosomes via
delivering additional cargo to amphisomes. Along these lines
macroautophagy has been described to transport source proteins
of microbial peptides to phagosomes (Alonso et al., 2007; Ponpuak
et al., 2010). These were found to be derived from ubiquitin itself
or proteins with ubiquitin-like domains, that were imported into
autophagosomes by some of the anchor proteins described above.
In part due to this cargo delivery autophagosome fusion with
phagosomes renders the resulting amphisomes more degrada-
tive for endocytosed bacterial pathogens (Gutierrez et al., 2004a;
Birmingham et al., 2006). ROS production by NOX2 and dia-
cylglycerol (DAG) formation at the phagosomal membrane was
proposed to enhance autophagosome fusion with bacteria con-
taining phagosomes (Huang et al., 2009; Shahnazari et al., 2010).
Thus, amphisome formation can enhance bactericidal activity of
phagosomes.
In addition, macroautophagy has been described to accel-
erate phagosome fusion with lysosomes (Sanjuan et al., 2007;
Florey et al., 2011). However, this pathway might not require
autophagosome fusion with lysosomes, but coupling of Atg8/LC3
to the phagosomal membrane (Figure 1). Accordingly, Atg8/LC3
co-localization to phagosomes and enhanced fusion of phago-
somes with lysosomes is dependent on the core machinery of
Atg8/LC3 lipidation, for example Atg5 and Atg7, but not on fac-
tors that are required for starvation induced macroautophagy, like
mTOR and Atg1/ULK1. Toll-like receptor (TLR) agonist carry-
ing particles and apoptotic cells have been identiﬁed in Atg8/LC3
positive phagosomes. How Atg8/LC3 on the outside of the phago-
some, however,mediates enhanced fusion with lysosomes remains
unclear. It is tempting to speculate thatAtg8/LC3,which is involved
in autophagosome membrane extension by possibly mediating
fusion with additional membranes (Nakatogawa et al., 2007; Wei-
dberg et al., 2011a), could also promote other vesicular fusion
events directly, like phagosome fusion with lysosomes. Irrespective
of the mechanism, the macroautophagy machinery seems to mod-
ify phagocytosis by delivering precursors of bactericidal peptides
to phagosomes and accelerating their fusion with lysosomes.
ENHANCED EXTRACELLULAR ANTIGEN PROCESSING VIA
MACROAUTOPHAGY
Although rapid degradation of phagosomal content rather
destroys antigens than leads to their presentation and phago-
somes have been described to mature faster with the help of
the macroautophagy machinery, it was found that mice with
macroautophagy deﬁciency in their dendritic cell compartment
were less able to prime CD4+ T cell responses after herpes simplex
virus (HSV) infection (Lee et al., 2010). Similarly, HSV lack-
ing its ICP34.5 antigen, which blocks autophagosome formation
(Orvedahl et al., 2007), stimulates stronger CD4+ T cell responses
than wild-type HSV infection (Leib et al., 2009). Even so these
data could still suggest intracellular HSV antigen processing by
macroautophagy and cytosolic ovalbumin was also less efﬁciently
presented on MHC class II molecules by Atg5 deﬁcient dendritic
cells, in addition, extracellular ovalbumin was less efﬁciently pre-
sented to CD4+ T cells by macroautophagy deﬁcient dendritic
cells (Lee et al., 2010). This was correlated with less efﬁcient
recruitment of lysosomal hydrolases, particularly cathepsins, to
phagosomes in the absence of macroautophagy.However, towhich
extend this more rapid phagosome maturation with the help of
the macroautophagy machinery contributes to extracellular anti-
gen presentation on MHC class II molecules remains unknown,
and inﬂuenza antigen processing for MHC class II presentation
to CD4+ T cells was unaffected by macroautophagy inhibition
(Comber et al., 2011). Therefore, CD4+ T cell responses only to
some, but not other pathogens might be dependent on macroau-
tophagy in dendritic cells for their induction, and the mechanism
of macroautophagic assistance for extracellular antigen processing
onto MHC class II molecules remains poorly deﬁned.
CONCLUSION AND OUTLOOK
Macroautophagy delivers cytoplasmic constituents for lysosomal
degradation. This machinery is also used to visualize intracellular
antigens to CD4+ T cells by processing them for MHC class II
presentation. However, in the process of studying dependency of
antigen processing on macroautophagy an additional pathway was
revealed, by which macroautophagy inﬂuences extracellular anti-
genprocessing forMHCclass II presentation toCD4+ Tcells.How
coupling of Atg8/LC3 to the phagosomal membrane, however,
modiﬁes phagosome maturation, potentially accelerating fusion
with lysosomes remains unknown. Furthermore, the role of this
accelerated phagosome maturation for MHC class II presentation
remains to be determined. A better understanding of these mol-
ecular processes during antigen presentation should allow us to
design antigens that are then more efﬁciently processed for CD4+
T cell stimulation and choose adjuvants, like TLR agonists, that
utilize macroautophagy to optimize antigen presentation.
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